Search research articles
Contact Us
Filters
Showing results (661-670 of 762) with videos related to
Page
of 77
Sort By:
Cancer
|
July 20, 2016
National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?
Brandon A Mahal, Yu-Wei Chen, Vinayak Muralidhar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 25, 2025
Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial
A Tripathi, Y Chen, D F Jarrard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States
B A Mahal, Y-W Chen, V Muralidhar, et al.
Molecular Oncology
|
May 28, 2025
Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab
Charles Swanton, Russell W Madison, Candice Francheska B Tambaoan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2006
Phase I and pharmacokinetic study of pemetrexed administered every 3 weeks to advanced cancer patients with normal and impaired renal function
Alain C Mita, Christopher J Sweeney, Sharyn D Baker, et al.
Urology
|
July 1, 2014
Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups
Brandon A Mahal, Ayal A Aizer, David R Ziehr, et al.
Seizure
|
October 1, 2023
Vagus nerve stimulation in refractory idiopathic generalised epilepsy: An Irish retrospective observational study
Javier Peña-Ceballos, Patrick B Moloney, Antonio Valentin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 7, 2010
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors
D J Jonker, L S Rosen, M B Sawyer, et al.
The Lancet. Oncology
|
August 2, 2021
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
Milind Javle, Mitesh J Borad, Nilofer S Azad, et al.
European Urology Oncology
|
December 12, 2024
Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer
Mark C Markowski, Yi Ren, Meghan Tierney, et al.
Page
of 77
Search research articles
Search
Showing results (661-670 of 762) with videos related to
Sort By:
Page
of 77
Cancer
|
July 20, 2016
National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?
Brandon A Mahal, Yu-Wei Chen, Vinayak Muralidhar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 25, 2025
Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial
A Tripathi, Y Chen, D F Jarrard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States
B A Mahal, Y-W Chen, V Muralidhar, et al.
Molecular Oncology
|
May 28, 2025
Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab
Charles Swanton, Russell W Madison, Candice Francheska B Tambaoan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2006
Phase I and pharmacokinetic study of pemetrexed administered every 3 weeks to advanced cancer patients with normal and impaired renal function
Alain C Mita, Christopher J Sweeney, Sharyn D Baker, et al.
Urology
|
July 1, 2014
Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups
Brandon A Mahal, Ayal A Aizer, David R Ziehr, et al.
Seizure
|
October 1, 2023
Vagus nerve stimulation in refractory idiopathic generalised epilepsy: An Irish retrospective observational study
Javier Peña-Ceballos, Patrick B Moloney, Antonio Valentin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 7, 2010
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors
D J Jonker, L S Rosen, M B Sawyer, et al.
The Lancet. Oncology
|
August 2, 2021
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
Milind Javle, Mitesh J Borad, Nilofer S Azad, et al.
European Urology Oncology
|
December 12, 2024
Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer
Mark C Markowski, Yi Ren, Meghan Tierney, et al.
Page
of 77